BR0011478A - Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal - Google Patents

Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal

Info

Publication number
BR0011478A
BR0011478A BR0011478-2A BR0011478A BR0011478A BR 0011478 A BR0011478 A BR 0011478A BR 0011478 A BR0011478 A BR 0011478A BR 0011478 A BR0011478 A BR 0011478A
Authority
BR
Brazil
Prior art keywords
methods
intranasal administration
composition
immunizing
inducing
Prior art date
Application number
BR0011478-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Robert C Huebner
Jacquelyn S Sampson
George M Carlone
Edwin Ades
David E Briles
Original Assignee
Uab Research Foundation
Aventis Pasteur
Ct S For Disease Control And P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Research Foundation, Aventis Pasteur, Ct S For Disease Control And P filed Critical Uab Research Foundation
Publication of BR0011478A publication Critical patent/BR0011478A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR0011478-2A 1999-06-10 2000-06-09 Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal BR0011478A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13842299P 1999-06-10 1999-06-10
US58783300A 2000-06-06 2000-06-06
PCT/US2000/040176 WO2000076541A1 (en) 1999-06-10 2000-06-09 Pneumococcal surface protein combination vaccine

Publications (1)

Publication Number Publication Date
BR0011478A true BR0011478A (pt) 2002-03-19

Family

ID=26836182

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0011478-2A BR0011478A (pt) 1999-06-10 2000-06-09 Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal

Country Status (7)

Country Link
EP (1) EP1189632A4 (de)
JP (1) JP2003519089A (de)
AU (1) AU6121000A (de)
BR (1) BR0011478A (de)
CA (1) CA2379327A1 (de)
MX (1) MXPA01012721A (de)
WO (1) WO2000076541A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078042B2 (en) * 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
EP1477802A1 (de) * 2003-05-16 2004-11-17 Erasmus Universiteit Rotterdam Verfahren zur Auswahl und zum Herstellung von Impfstoffkomponenten, und deren Verwendung in Impfstoffen
WO2008022302A2 (en) * 2006-08-17 2008-02-21 The Uab Research Foundation Immunogenic pcpa polypeptides and uses thereof
RU2510281C2 (ru) * 2012-06-22 2014-03-27 Общество с ограниченной ответственностью "Эпитоп" (ООО "Эпитоп") ВАКЦИНА ПРОТИВ ПНЕВМОНИИ, ВЫЗЫВАЕМОЙ Streptococcus pneumoniae, НА ОСНОВЕ ГИБРИДНОГО БЕЛКА
GB201318170D0 (en) * 2013-10-14 2013-11-27 Univ Edinburgh Proteins with Diagnostic and Therapeutic Uses
KR101627285B1 (ko) * 2014-06-05 2016-06-07 한국생명공학연구원 ＰｓｐＡ를 유효성분으로 포함하는 퇴행성 뇌질환의 예방 또는 치료용 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
WO1994014318A1 (en) * 1992-12-24 1994-07-07 Medimmune, Inc. Method of protection against streptococcus pneumoniae with transformed mycobacteria
WO1999045121A1 (en) * 1998-03-02 1999-09-10 The Government Of The United States Of America, Represented By The Secretary Of The Department Health And Human Services EPITOPE PEPTIDES IMMUNOGENIC AGAINST $i(STREPTOCOCCUS PNEUMONIAE)
CA2328399A1 (en) * 1998-04-23 1999-10-28 University Of Alabama At Birmingham Pneumococcal surface protein c(pspc), epitopic regions and strain selection thereof, and uses therefor

Also Published As

Publication number Publication date
JP2003519089A (ja) 2003-06-17
EP1189632A1 (de) 2002-03-27
EP1189632A4 (de) 2002-08-21
CA2379327A1 (en) 2000-12-21
AU6121000A (en) 2001-01-02
WO2000076541A1 (en) 2000-12-21
MXPA01012721A (es) 2004-10-14

Similar Documents

Publication Publication Date Title
BRPI0010612B8 (pt) vacinas
BR0113822A (pt) Vacina
BR0009166A (pt) Vacina
BR0108828A (pt) Formulação de carboidrato (adjuvante pré-biótico) para aperfeiçoamento de resposta imuno
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
MX2008013993A (es) Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular.
HK1043943A1 (zh) 肺炎鏈球菌蛋白質和疫苗
NO964413L (no) Gruppe A streptokokkisk polysakkarid, immunogene blandinger derav samt anvendelse derav
PT835133E (pt) Composições recombinantes de poxvírus-raiva e composições de combinação e suas utilizações
EP0090581A3 (de) Kleine, für Maul- und Klauenseuche spezifische Peptide
MY125000A (en) Novel compositions
HUP0103502A2 (hu) Streptococcus Cbéta-fehérje készítmények
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
WO2001081380A3 (en) Immunogenic pneumococcal protein and vaccine compositions thereof
WO2000058475A3 (en) Streptococcus pneumoniae antigens
BR0011478A (pt) Composição de combinação imunológica, métodos de induzir uma resposta imunológica em um animal, e de imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal
EP0775746A3 (de) Impfstoff gegen Geflügelkokzidose
AU8467201A (en) Compositions for and methods of using herpes simplex virus glycoprotein d to suppress immune responses
WO2001034184A3 (en) Methods and compositions for protection against bovine herpesvirus 1
WO2004041182A3 (en) M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
MY127452A (en) Vaccines.
UA42741C2 (uk) Пептид маститної вакцини (варіанти), пептид складного антигенного представлення (варіанти), фармацевтична композиція (варіанти)
BR9905780A (pt) Antìgenos vacinais de leptospira para prevenção da laptospirose
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.